Cargando…
IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway
BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related deaths, and it is also the most frequently diagnosed cancer. Previous studies indicate that IL-33 plays a crucial role in the development of NSCLC. In recent years, the role of miRNAs in cancer has become i...
Autores principales: | Zhou, Xiaorong, Feng, Yuxu, Liu, Siwen, Li, Chenchen, Teng, Yue, Li, Xiaoyou, Lu, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965692/ https://www.ncbi.nlm.nih.gov/pubmed/33737835 http://dx.doi.org/10.2147/CMAR.S276297 |
Ejemplares similares
-
IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Corrigendum]
Publicado: (2021) -
IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway [Retraction]
Publicado: (2023) -
β-Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3-Mediated N(6) Methyladenosine Modification
por: Feng, Yuxu, et al.
Publicado: (2022) -
MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells
por: Yang, Yi, et al.
Publicado: (2016) -
Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway
por: Li, Chenchen, et al.
Publicado: (2018)